HLA-DQA1*05-DQB1*0201 positivity predisposes to coeliac disease in Czech diabetic children

Acta paediatrica (Oslo, Norway : 1992)

Volumn 89, Issue 12, 2000, Pages 1426-1430

  Sumnik Z ^a   Kolouskova S ^a   Cinek, O ^a   Kotalova R ^a   Vavrinec J ^a   Snajderova M ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

DIAGNOSTIC AGENT; HLA DQ ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CELIAC DISEASE; CHILD; CZECH REPUBLIC; FEMALE; GENETICS; GENOTYPE; HUMAN; IMMUNOLOGY; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PRESCHOOL CHILD; PREVALENCE;

ADOLESCENT; ADULT; CELIAC DISEASE; CHILD; CHILD, PRESCHOOL; CZECH REPUBLIC; DIABETES MELLITUS, TYPE 1; FEMALE; GENOTYPE; HLA-DQ ANTIGENS; HUMANS; INFANT; MALE; PREVALENCE;

EID: 0034572151     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2000.tb02770.x     Document Type: Article

References (30)

1. 1 Cronin C, Shanahan F. Insulin‐dependent diabetes mellitus and coeliac disease. Lancet 1997 ; 349: 1096–7.
2. 2 De Vitis I, Ghirlanda G, Gasbarrini G. Prevalence of coeliac disease in type I diabetes: a multicentre study. Acta Paediatr Suppl 1996 ; 412: 56–7.
3. 3 Carlsson AK, Axelsson IE, Borulf SK, Bredberg AC, Lindberg BA, Sjoberg KG, et al. Prevalence of IgA‐antiendomysium and IgA‐antigliadin autoantibodies at diagnosis of insulin‐dependent diabetes mellitus in Swedish children and adolescents. Pediatrics 1999 ; 103: 1248–52.
4. 4 Koletzko S, Burgin‐Wolff A, Koletzko B, Knapp M, Burger W, Gruneklee D, et al. Prevalence of coeliac disease in diabetic children and adolescents. A multicentre study. Eur J Pediatr 1988 ; 148: 113–7.
5. 5 Logan RFA. Screening for coeliac disease—has the time come for mass screening Acta Paediatr 1996 ; Suppl 412: 15–9.
6. 6 Sigurs N, Johansson C, Elfstrand PO, Viander M, Lanner A. Prevalence of coeliac disease in diabetic children and adolescents in Sweden. Acta Paediatr 1993 ; 82: 748–51.
7. 7 Cronin C, Feighery A, Ferriss JB, Liddy C, Shanahan F, Feighery C. High prevalence of celiac disease among patients with insulin‐dependent (type I) diabetes mellitus. Am J Gastroenterol 1997 ; 92: 2210–2.
8. 8 Acerini CL, Ahmed ML, Ross KM, Sullivan PB, Bird G, Dunger DB. Coeliac disease in children and adolescents with IDDM: clinical characteristics and response to gluten‐free diet. Diabet Med 1998 ; 15: 38–44.
9. 9 Unsworth DJ, Brown DL. Serological screening suggests that adult coeliac disease is underdiagnosed in the UK and increases the incidence by up to 12%. Gut 1994 ; 35: 61–4.
10. 10 Hed J, Lieden G, Ottosson E, Strom M, Walan A, Groth O, et al. IgA anti‐gliadin antibodies and jejunal mucosal lesions in healthy blood donors [Letter]. Lancet 1986 ; 2: 215.
11. 11 Catassi C, Ratsch IM, Fabiani E, Ricci S, Bordicchia F, Pierdomenico et al. High prevalence of undiagnosed coeliac disease in 5280 Italian students screened by antigliadin antibodies. Acta Paediatr 1995 ; 84: 672–6.
12. 12 Holmes GK. Non‐malignant complications of coeliac disease. Acta Paediatr Suppl 1996 ; 412: 68–75.
13. 13 Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease‐effect of a gluten free diet. Gut 1989 ; 30: 333–8.
14. 14 Lernmark A. Molecular biology of IDDM. Diabetologia 1994 ; 37: S73–81.
15. 15 Sollid LM, Thorsby E. HLA susceptibility genes in celiac disease: genetic mapping and role of pathogenesis. Gastroenterology 1993 ; 105: 910–22.
16. 16 Lie B, Sollid L, Ascher H, Ek J, Akselsen HE, Ronningen KS, et al. A gene telomeric of the HLA class I region is involved in predisposition to both type 1 diabetes and coeliac disease. Tissue Antigens 1999 ; 52: 162–8.
17. 17 Djilali‐Saiah I, Schmitz J, Harfouch‐Hammoud E, Mougenot JF, Bach JF, Caillat‐Zucman S. CTLA‐4 gene polymorphism is associated with predisposition to coeliac disease. Gut 1998 ; 43: 187–9.
18. 18 Houlston RS, Ford D. Genetics of coeliac disease. Qjm 1996 ; 89: 737–43.
19. 19 Pena AS, Garrote JA, Crusius JB. Advances in the immunogenetics of coeliac disease. Clues for understanding the pathogenesis and disease heterogeneity. Scand J Gastroenterol Suppl 1998 ; 225: 56–8.
20. 20 Polvi A, Arranz E, Fernandez‐Arquero M, Collin P, Maki M, Sanz A, et al. HLA‐DQ2‐negative celiac disease in Finland and Spain. Hum Immunol 1998 ; 59: 169–75.
21. 21 Walker‐Smith J, Guandalini S, Schmitz J, Shmerling D, Visakorpi J. Revised criteria for diagnosis of coeliac disease. Arch Dis Child 1990 ; 65: 909–11.
22. 22 Olerup O, Aldener A, Fogdell A. HLA‐DQB1 and ‐DQA1 typing by PCR amplification with sequence‐specific primers (PCR‐SSP) in 2 hours. Tissue Antigens 1993 ; 41: 119–34.
23. 23 Fraser‐Reynolds KA, Butzner JD, Stephure DK, Trussell RA, Scott RB. Use of immunoglobulin A‐antiendomysial antibody to screen for celiac disease in North American children with type 1 diabetes. Diabetes Care 1998 ; 21: 1985–9.
24. 24 Kotalova R, Nevoral J, Smidova J. Tissue antibodies in the diagnosis of coeliac sprue. Cs Pediatr 1996 ; 51: 680–7.
25. 25 Holtmeier W, Caspary W. Diagnostic use of antibodies in celiac disease. Z Gastroenterol 1998 ; 36: 587–97.
26. 26 Meini A, Pillan NM, Villanacci V, Monafo V, Ugazio AG, Plebani A. Prevalence and diagnosis of celiac disease in IgA‐deficient children. Ann Allergy Asthma Immunol 1996 ; 77: 333–6.
27. 27 Bao F, Yu L, Babu S, Wang T, Hoffenberg EJ, Rewers M, et al. One third of HLA DQ2 homozygous patients with type 1 diabetes express celiac disease‐associated tranglutaminase autoantibodies. J Autoimmun 1999 ; 13: 143–8.
28. 28 Congia M, Cucca F, Frau F, Lampis R, Melis L, Clemente MG, et al. A gene dosage effect of the DQA1*0501/DQB1*0201 allelic combination influences the clinical heterogeneity of celiac disease. Hum Immunol 1994 ; 40: 138–42.
29. 29 Ploski R, Ek J, Thorsby E, Sollid L. On the HLA‐DQ(al*0501, bl*0201)‐associated susceptibility in celiac disease: a possible gene dosage effect of DQB1*0201. Tissue Antigens 1993 ; 41: 173–7.
30. 30 Dorman JS. Molecular epidemiology of insulin‐dependent diabetes mellitus. Epidemiol Rev 1997 ; 19: 91–8.